Liz Morrell
MA MSc PhD FHEA
Senior Researcher
Liz joined HERC in February 2018, from the Centre for the Advancement of Sustainable Medical Innovation (CASMI) - a policy research group in Oxford’s Radcliffe Department of Medicine. Her work focused on the health economics of cancer drugs, exploring the impact of technology appraisal processes on patient access to drugs, and the value that society places on treating cancer relative to other conditions.
Before joining CASMI, Liz worked as a freelance researcher with clients in pharmaceuticals and education, and as a product development manager in consumer healthcare.
Liz is working with Sarah Wordsworth and colleagues, initially on a series of Discrete Choice Experiments exploring clinician and public attitudes to antibiotics and antimicrobial resistance.
Recent publications
-
Impact of the COVID-19 Pandemic on Community Antibiotic Prescribing and Stewardship: A Qualitative Interview Study with General Practitioners in England
Borek AJ. et al, (2021), Antibiotics, 10, 1531 - 1531
-
Impact of the COVID-19 pandemic on community antibiotic prescribing and stewardship: a qualitative interview study with general practitioners in England
BOREK A. et al, (2021), medRxiv
-
Development of an intervention to support the implementation of evidence-based strategies for optimising antibiotic prescribing in general practice
BOREK A. et al, (2021), Implementation Science Communications
-
What aspects of illness influence public preferences for healthcare priority setting? A discrete choice experiment in the UK
MORRELL E. et al, (2021), PharmacoEconomics
-
Preferences for Medical Consultations from Online Providers: Evidence from a Discrete Choice Experiment in the United Kingdom
BUCHANAN J. et al, (2021), Applied Health Economics and Health Policy